• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

EU (govt)

	Region	Brussels
	Country	Belgium
	City	n. a. Brussels
		Address record changed: 2011-11-27
Basic data	Employees	n. a.
		Record changed: 2019-04-05

Advertisement

More documents for EU (govt)

• [1] Bluebird Bio, Inc.. (6/3/19). "Press Release: Bluebird Bio Announces EU Conditional Marketing Authorization for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA....
• [2] Mobidiag Oy. (5/14/19). "Press Release: Investment Plan for Europe – Mobidiag Secures EUR 25 million from EIB"....
• [3] Enzyre B.V.. (4/30/19). "Press Release: Enzyre Appoints Dirk Pollet as Chief Executive Officer. Awarded €2M Grant and Completes Seed Financing". Nijmegen....
• [4] Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA....
• [5] Bluebird Bio, Inc.. (3/29/19). "Press Release: Bluebird Bio Receives Positive Opinion from CHMP for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA....
• [6] Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA....
• [7] MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg....
• [8] Innovative Medicines Initiative (IMI). (1/22/19). "Press Release: Open Access Drug Development Tools Feature in New IMI Call for Proposals". Brussels....
• [9] Samplix ApS. (1/10/19). "Press Release: Samplix Wins €1.9 Million in Prestigious Horizon 2020 – SME Instrument Program"....
• [10] OncoImmunity AS. (12/17/18). "Press Release: OncoImmunity Receives €2.2 Million to Roll Out Its Machine-learning Platform to Enable the Development of Personalized Cancer Immunotherapies". Oslo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.